CYPHERPUNK TECHNOLOGIES INC. Operating Lease, Liability, Current
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Operating Lease, Liability, Current of $38.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $38.00K.
- 2026-03-31: Operating Lease, Liability, Current $38.00K.
- 2025-12-31: Operating Lease, Liability, Current $38.00K.
- 2025-09-30: Operating Lease, Liability, Current $38.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $38.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $38.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $38.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $38.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $39.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $154.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $266.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $376.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $443.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $430.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $262.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $369.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $436.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $425.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $416.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $405.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $395.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $363.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $432.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | $323.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $354.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $418.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $408.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $398.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $388.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $379.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $474.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $566.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $657.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $738.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |